Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.12.20	Coronavirus Vaccine Rollout In U.S. Has Begun (RTTNews)
14.12.20	UPS, FedEx To Transport Initial Pfizer-BioNTech COVID-19 Vaccine Doses (RTTNews)
14.12.20	Pfizer, BioNTech Report Data From German Phase 1/2 Trial With COVID-19 Vaccine Candidate (RTTNews)
14.12.20	US Covid-19 Vaccinations To Begin Monday As CDC Recommends Pfizer Vaccine (RTTNews)
12.12.20	U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older (Businesswire)
12.12.20	Pfizer Says Prepared To Deliver First Doses Of COVID-19 Vaccine In U.S. Immediately (RTTNews)
12.12.20	Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19 (Businesswire)
12.12.20	FDA Authorizes Emergency Use Of Pfizer, BioNTech's COVID-19 Vaccine (RTTNews)
12.12.20	FDA Issues Emergency Use Authorization For Pfizer, BioNTech's COVID-19 Vaccine (RTTNews)
12.12.20	Walgreens Says Preparing To Immediately Bring Pfizer COVID-19 Vaccine To High-priority Populations (RTTNews)
11.12.20	FDA Says 'to Rapidly Work Toward' Emergency Use Approval Of Pfizer Covid-19 Vaccine (RTTNews)
11.12.20	Merck KGaA, Pfizer: CHMP Recommends Approval Of BAVENCIO - Quick Facts (RTTNews)
11.12.20	Pfizer Declares First-Quarter 2021 Dividend (Businesswire)
11.12.20	FDA Panel Recommends Emergency Use Of Pfizer, BioNTech's COVID-19 Vaccine (RTTNews)
11.12.20	Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S. (Businesswire)
10.12.20	Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine (Businesswire)
08.12.20	U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age and Older (Businesswire)
08.12.20	FDA Says Pfizer/BioNTech COVID-19 Vaccine Has "Favorable Safety Profile" (RTTNews)
08.12.20	WSJ: FDA Says Pfizer/BioNTech COVID-19 Vaccine Met Prescribed Success Criteria (RTTNews)
08.12.20	Canada In Deal With Pfizer For Covid-19 Vaccine As UK Begins Vaccination (RTTNews)
07.12.20	Pfizer Reports Positive Data From Ongoing Phase 1 Study For PF-06863135 In Multiple Myeloma (RTTNews)
07.12.20	Pfizer, Sangamo Report Encouraging Findings From Phase 1/2 Study Of Giroctocogene Fitelparvovec (RTTNews)
07.12.20	Pfizer Reports Positive Clinical Data for BCMA-CD3 Bispecific Antibody (PF-06863135) in Multiple Myeloma (Businesswire)
07.12.20	Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy (Businesswire)
07.12.20	Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...) (RTTNews)
03.12.20	BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK (RTTNews)
02.12.20	Stock Alert: Pfizer Shares Hit 52-Week High (RTTNews)
02.12.20	Pre-market Movers In Healthcare Sector: ZOM, BNTX, PFE, MESO, OVID… (RTTNews)
02.12.20	Pfizer, BioNTech's COVID-19 Vaccine Gets UK's Emergency Authorization (RTTNews)
02.12.20	U.K. Grants Temporary Authorization For Emergency Use For Pfizer/BioNTech COVID-19 Vaccine (RTTNews)
02.12.20	Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19 (Businesswire)
01.12.20	EMA Receives CMA Application For BioNTech/Pfizer And Moderna COVID-19 Vaccines (RTTNews)
01.12.20	Pfizer, BioNTech Apply For COVID-19 Vaccine's Marketing Authorization In EU (RTTNews)
01.12.20	Pfizer, BioNTech Apply For Conditional Marketing Authorization For COVID-19 Vaccine To EMA (RTTNews)
30.11.20	Biotech Stocks Facing FDA Decision In December 2020 (RTTNews)
26.11.20	The Long And Short Of Pfizer-BioNTech, Moderna, Sputnik V & Oxford-AstraZeneca Vaccines (RTTNews)
25.11.20	Basilea: Pfizer's MAA For Cresemba Accepted For Regulatory Review In China (RTTNews)
24.11.20	AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles (RTTNews)
23.11.20	Pfizer Doses First Participant In Phase 3 BASIS Study Of Marstacimab - Quick Facts (RTTNews)
23.11.20	Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors (Businesswire)
20.11.20	Pfizer, BioNTech To Submit Emergency Use Authorization Request To FDA For COVID-19 Vaccine (RTTNews)
20.11.20	Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine (Businesswire)
20.11.20	AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B (RTTNews)
19.11.20	Results from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine (Businesswire)
19.11.20	APVO Gets Buyout Offer, PFE/BNTX' COVID Shot 95% Effective, CORT Gets Favorable PTAB Ruling (RTTNews)
18.11.20	Pfizer Says COVID-19 Vaccine 95% Effective; To Apply For Emergency Use (RTTNews)
18.11.20	Pfizer-BioNTech Covid-19 Vaccine Found To Be 95% Effective - Quick Facts (RTTNews)
18.11.20	Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints (Businesswire)
18.11.20	Vivet : FDA Authorizes To Proceed With Phase 1/2 Study On Gene Therapy For Wilson Disease (RTTNews)
17.11.20	ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

25.12.24		Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel hätten Anleger an einem Johnson Johnson-Investment von vor 3 Jahren verloren
24.12.24		Börse New York: Dow Jones zeigt sich zum Handelsende fester
24.12.24		Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen
24.12.24		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
24.12.24		Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50
24.12.24		Dienstagshandel in London: Letztendlich Gewinne im FTSE 100
24.12.24		Börse Europa in Grün: STOXX 50 steigt schlussendlich

25.12.24

Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel hätten Anleger an einem Johnson Johnson-Investment von vor 3 Jahren verloren

24.12.24

Börse New York: Dow Jones zeigt sich zum Handelsende fester

24.12.24

Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen

24.12.24

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

24.12.24

Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50

24.12.24

Dienstagshandel in London: Letztendlich Gewinne im FTSE 100